Prenatal screening and diagnosis for pediatricians

Pediatrics

Volumn 114, Issue 3, 2004, Pages 889-894

  Cunniff, Christopher ^a  

^a NONE

Author keywords

fetoproteins; Amniocentesis; Chorionic villi sampling; Chromosome aberrations; Genetic counseling; Genetic screening; Neural tube defects; Preimplantation diagnosis; Prenatal diagnosis; Prenatal ultrasonography

Indexed keywords

ALPHA FETOPROTEIN;

AMNIOCENTESIS; ARTICLE; BIOCHEMISTRY; BIRTH DEFECT; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME MOSAICISM; EARLY DIAGNOSIS; FETUS BLOOD; FETUS BLOOD SAMPLING; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS ELECTROCARDIOGRAPHY; FRAGILE X SYNDROME; GENETIC DISORDER; GESTATIONAL AGE; HEALTH EDUCATION; HUMAN; MOLECULAR GENETICS; NEURAL TUBE DEFECT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT EDUCATION; PEDIATRICIAN; PEDIATRICS; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROBABILITY; SMITH LEMLI OPITZ SYNDROME; TAY SACHS DISEASE; X CHROMOSOME LINKED DISORDER; CONGENITAL MALFORMATION; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; METHODOLOGY; PREGNANCY; REVIEW;

ABNORMALITIES; ALPHA-FETOPROTEINS; CHROMOSOME ABERRATIONS; FEMALE; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC SCREENING; HUMANS; PEDIATRICS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 16544395878     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1368     Document Type: Article

References (42)

1. Creasy RK, Resnik R, eds. Maternal-Fetal Medicine. 4th ed. Philadelphia, PA: Saunders; 1999
2. Cunningham FG, ed. Williams Obstetrics. 21st ed. New York, NY: McGraw-Hill; 2001
3. Simpson JL, Elias S, eds. Genetics in Obstetrics and Gynecology. 3rd ed. Philadelphia, PA: Saunders; 2002
4. American Academy of Pediatrics, Committee on Genetics. Molecular genetic testing in pediatric practice: a subject review. Pediatrics. 2000;106:1494-1497
5. Korf B. Molecular diagnosis (1). N Engl J Med. 1995;332:1218-1220
6. Korf B. Molecular diagnosis (2) [published correction appears in N Engl J Med. 1995;333:331]. N Engl J Med. 1995;332:1499-1502
7. National Institute of Child Health and Human Development, National Registry for Amniocentesis Study Group. Midtrimester amniocentesis for prenatal diagnosis. Safety and accuracy. JAMA. 1976;236:1471-1476
8. Simpson NE, Dallaire L, Miller JR, et al. Prenatal diagnosis of genetic disease in Canada: report of a collaborative study. Can Med Assoc J. 1976;115:739-748
9. Assel BG, Lewis SM, Dickerman LH, Park VM, Jassani MN. Single-operator comparison of early and mid-second-trimester amniocentesis. Obstet Gynecol. 1992;79:940-944
10. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet. 1998;351:242-247
11. Nikkila A, Valentin L, Thelin A, Jorgensen C. Early amniocentesis and congenital foot deformities. Fetal Diagn Ther. 2002;17:129-132
12. Tredwell SJ, Wilson D, Wilmink MA, Canadian Early and Mid-Trimester Amniocentesis Trial Group (CEMAT), Canadian Orthopedic Review Group. Review of the effect of early amniocentesis on foot deformity in the neonate. J Pediatr Orthop. 2001;21:636-641
13. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities. Obstet Gynecol. 2001;97(5 pt 1):1-12
14. Jackson LG, Zachary JM, Fowler SE, et al. A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The US National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N Engl J Med. 1992;327:594-598
15. Medical Research Council European trial of chorion villus sampling. MRC working party on the evaluation of chorion villus sampling. Lancet. 1991;337:1491-1499
16. Lippman A, Tomkins DJ, Shime J, Hamerton JL. Canadian multicentre randomized clinical trial of chorion villus sampling and amniocentesis. Final report. Prenat Diagn. 1992;12:385-408
17. Smidt-Jensen S, Permin M, Philip J, et al. Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling. Lancet. 1992;340:1237-1244
18. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Lancet. 1989;1(8628):1-6
19. Johnson A, Wapner RJ, Davis GH, Jackson LG. Mosaicism in chorionic villus sampling: an association with poor perinatal outcome. Obstet Gynecol. 1990;75:573-577
20. Wapner RJ, Simpson JL, Golbus MS, et al. Chorionic mosaicism: association with fetal loss but not with adverse perinatal outcome. Prenat Diagn. 1992;12:347-355
21. Olney RS, Khoury MJ, Alo CJ, et al. Increased risk for transverse digital deficiency after chorionic villus sampling: results of the United States Multistate Case-Control Study, 1988-1992. Teratology. 1995;51:20-29
22. Froster UG, Jackson L. Limb defects and chorionic villus sampling: results from an international registry, 1992-94. Lancet. 1996;347:489-494
23. American College of Obstetricians and Gynecologists, Committee on Genetics. Chorionic villus sampling. ACOG Comm Opin. 1995;160:1-3
24. Tongsong T, Wanapirak C, Kunavikatikul C, Sirirchotiyakul S, Piyamongkol W, Chanprapaph P. Fetal loss rate associated with cordocentesis at midgestation. Am J Obstet Gynecol. 2001;184:719-723
25. Handyside AH, Lesko JG, Tarin JJ, Winston RM, Hughes MR. Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis. N Engl J Med. 1992;327:905-909
26. Limb CJ, Holmes LB. Anencephaly: changes in prenatal detection and birth status, 1972 through 1990. Am J Obstet Gynecol. 1994;170:1333-1338
27. Morrow RJ, McNay MB, Whittle MJ. Ultrasound detection of neural tube defects in patients with elevated maternal serum alpha-fetoprotein. Obstet Gynecol. 1991;78:1055-1057
28. Sepulveda W, Lopez-Tenorio J. The value of minor ultrasound markers for fetal aneuploidy. Curr Opin Obstet Gynecol. 2001;13:183-191
29. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Guidelines for diagnostic imaging during pregnancy. ACOG Comm Opin. 1995;158:1-4
30. Copel JA, Pilu G, Green J, Hobbins JC, Kleinman CS. Fetal echocardiographic screening for congenital heart disease: the importance of the four-chamber view. Am J Obstet Gynecol. 1987;157:648-655
31. American College of Obstetricians and Gynecologists. Maternal serum screening. ACOG Tech Bull. 1996;228:1-9
32. Lennon CA, Gray DL. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. Obstet Gynecol. 1999;94:562-566
33. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities. Am J Obstet Gynecol. 1984;148:886-894
34. Cuckle HS, Wald NJ, Lindenbaum RH. Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome. Lancet. 1984;1:926-929
35. Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Obstet Gynecol. 1992;80:353-358
36. Burton BK, Prins GS, Verp MS. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. Am J Obstet Gynecol. 1993;169:526-530
37. Benn PA. Advances in prenatal screening for Down syndrome: I. General principles and second trimester testing. Clin Chim Acta. 2002;323:1-16
38. Malone FD, D'Alton ME, Society for Maternal-Fetal Medicine. First-trimester sonographic screening for Down syndrome. Obstet Gynecol. 2003;102:1066-1079
39. Egan JF, Kaminsky LM, DeRoche ME, Barsoom MJ, Borgida AF, Benn PA. Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists. Am J Obstet Gynecol. 2002;187:1230-1234
40. Katz VL, Chescheir NC, Cefalo RC. Unexplained elevations of maternal serum alpha-fetoprotein. Obstet Gynecol Surv. 1990;45:719-726
41. Simpson JL, Palomaki GE, Mercer B, et al. Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements. Am J Obstet Gynecol. 1995;173:1742-1748
42. Krause TG, Christens P, Wohlfahrt J, et al. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome (1). Obstet Gynecol. 2001;97:277-282